Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.


Rogers, ME; Sizova, OV; Ferguson, MA; Nikolaev, AV; Bates, PA; (2006) Synthetic glycovaccine protects against the bite of leishmania-infected sand flies. The Journal of infectious diseases, 194 (4). pp. 512-8. ISSN 0022-1899 DOI: 10.1086/505584

Full text not available from this repository. (Request a copy)

Abstract

Leishmaniasis is a vectorborne disease transmitted to human and other mammalian hosts by sand fly bite. In the present study, we show that immunization with Leishmania mexicana promastigote secretory gel (PSG) or with a chemically defined synthetic glycovaccine containing the glycans found in L. mexicana PSG can provide significant protection against challenge by the bite of infected sand flies. Only the glycan from L. mexicana was protective; those from other species did not protect against L. mexicana infection. Furthermore, neither PSG nor the glycovaccine protected against artificial needle challenge, which is traditionally used in antileishmanial vaccine development. Conversely, an antigen preparation that was effective against needle challenge offered no protection against sand fly bite. These findings provide a new target for Leishmania vaccine development and demonstrate the critical role that the vector plays in the evaluation of candidate vaccines for leishmaniasis and other vectorborne diseases.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Leishmaniasis Group
Vaccine Centre
PubMed ID: 16845636
Web of Science ID: 239121000015
URI: http://researchonline.lshtm.ac.uk/id/eprint/2050

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
284Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item